Using a device to recover platelets during cardiac surgery
Study of Platelet Count Changes During the Use of Autotransfusion Device in Cardiac Surgery
This study tests if a special device that collects and returns your own blood during heart surgery can help keep your platelet levels up and reduce the need for blood transfusions.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg, Bas-Rhin) |
| Trial ID | NCT06629311 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the effectiveness of an intraoperative autotransfusion device in recovering platelets during standard cardiac surgery. The device is designed to aspirate, process, and retransfuse the patient's own blood, potentially reducing the need for external blood transfusions. The study will monitor platelet counts in adult patients who have consented to participate and have undergone the specified surgical procedures. By evaluating real-life outcomes, the study aims to provide insights into the device's performance in clinical settings.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old undergoing standard cardiac surgery who can consent to the study.
Not a fit: Patients with anemia less than 7 g/dL, pregnant women, or those undergoing specific excluded surgical procedures will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance patient safety by reducing the need for blood transfusions during cardiac surgery.
How similar studies have performed: While the use of autotransfusion devices is common, this specific evaluation of platelet recovery in real-life situations is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over 18 years of age * Having undergone standard cardiac surgery (excluding redux surgery, dissection, endocarditis, circulatory assist and transplants) * Treated with an autotransfusion device during the surgery * Subject having expressed their consent to the study Exclusion Criteria: * Anemia less than 7 g/dL * Pregnant women * Redux surgery, dissection, endocarditis, circulatory assistance, and transplants * Contraindication to the use of an autotransfusion device * Impossibility of giving the subject informed information
Where this trial is running
Strasbourg, Bas-Rhin
- Hôpitaux Universitaires de Strasbourg — Strasbourg, Bas-Rhin, France (Recruiting)
Study contacts
- Study coordinator: Charles TACQUARD, PHU
- Email: charlesambroise.tacquard@chru-strasbourg.fr
- Phone: +33 6 69 55 16 08
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.